These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8786629)

  • 1. [Efficacy of cefditoren pivoxil in the treatment of acute otitis media due to benzylpenicillin-insensitive Streptococcus pneumoniae].
    Sugita R; Deguchi K; Kimura S; Harada S; Fujimaki Y; Watanabe H; Naito M; Nomura T; Tanaka M; Komatsu N; Shimizu K; Yoshida Y; Okano K
    Jpn J Antibiot; 1996 Apr; 49(4):386-98. PubMed ID: 8786629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
    Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
    Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains].
    Sugita R; Deguchi K; Fujimaki Y; Harada S; Shimizu K; Kimura S; Watanabe H; Komatsu N; Okano K; Naito M; Nomura T; Tanaka M; Yoshida Y; Tanaka H; Iwai N; Nakamura H
    Jpn J Antibiot; 1997 Aug; 50(8):727-37. PubMed ID: 9339399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
    Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
    Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
    Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H
    Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients].
    Ishihara R; Ishii Y; Suzuki Y; Nakazawa A; Deguchi K; Toyonaga Y
    Jpn J Antibiot; 1998 Jan; 51(1):1-10. PubMed ID: 9557272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of bacterial strain at each episode of recurrent acute otitis media].
    Suetake M; Irimada M; Takahashi S; Ohyama K; Ubukata K
    Nihon Jibiinkoka Gakkai Kaiho; 2000 Jan; 103(1):19-23. PubMed ID: 10695333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
    Matsumoto K; Sugano T; Sato N; Ida T; Shibasaki S
    Jpn J Antibiot; 2014 Feb; 67(1):33-47. PubMed ID: 24809207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].
    Nakamura T; Takahashi H
    Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections].
    Shimada J; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Deguchi K
    Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial activities of cefditoren against clinical isolates obtained from outpatients].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Kumoto T
    Jpn J Antibiot; 1994 Oct; 47(10):1369-78. PubMed ID: 7807697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days].
    Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K
    Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.